| Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis (NCT05272150) | Janssen Research & Development, LLC | 2022-07-13 |
| Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR) (NCT05028582) | Arcutis Biotherapeutics, Inc. | 2021-08-24 |
| A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis (NCT04243486) | Therapeutics, Inc. | 2020-01-02 |
| Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis (NCT03897088) | Sun Pharmaceutical Industries Limited | 2019-03-29 |
| Evaluate the Efficacy and Safety of Boroda Supramolecular Active Zinc in the Treatment of Scalp Psoriasis (NCT04801433) | Xijing Hospital | 2018-11-30 |
| To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis (NCT03880357) | Sun Pharmaceutical Industries, Inc. | 2018-10-22 |
| To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp Psoriasis (NCT03331523) | Glenmark Pharmaceuticals Ltd. India | 2017-10-20 |
| BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis (NCT03122353) | Tolmar Inc. | 2017-04-11 |
| Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product (NCT02933502) | Sun Pharmaceutical Industries, Inc. | 2016-07-11 |
| Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis (NCT02933866) | Sun Pharmaceutical Industries, Inc. | 2016-03-11 |
| Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis (NCT02932462) | Sun Pharmaceutical Industries, Inc. | 2016-03-01 |
| Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis (NCT02749656) | Siriraj Hospital | 2016-01-01 |
| IL-17 Role in Variants of Psoriasis (NCT02078297) | Innovaderm Research Inc. | 2014-02-01 |
| A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis (NCT01558310) | Paul Steven Yamauchi, MD, PhD | 2012-08-01 |
| Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis (NCT01120223) | LEO Pharma | 2010-05-01 |
| Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis (NCT01083758) | LEO Pharma | 2010-04-01 |
| Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel) (NCT01052467) | LEO Pharma | 2010-01-01 |
| Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp (NCT00881868) | Galderma R&D | 2009-04-01 |
| Subject Preference for Scalp Psoriasis Treatment (NCT00438399) | Galderma R&D | 2007-02-01 |
| Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis (NCT00400725) | Galderma R&D | 2006-09-29 |